Literature DB >> 2473030

Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules.

F Lozano1, J Santos-Aguado, L Borche, L Places, N Doménech, A Gayá, R Vilella, J Vives.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2473030     DOI： 10.1007/bf02421470

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  12 in total

Review 1.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation.

Authors:  D S Taylor; P C Nowell; J Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  A new public antigen shared by all HLA-A locus products except HLA-A23, -A24, -A32, and -A25 is probably influenced by the amino acid residue at position 79 in the alpha 1 domain.

Authors:  L P de Waal; C van der Meer; A R van der Horst; F H van der Velde
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.

Authors:  J Santos-Aguado; J A Barbosa; P A Biro; J L Strominger
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

5.  Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.

Authors:  N Doménech; A Ezquerra; R Castaño; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Nature of polymorphism in HLA-A, -B, and -C molecules.

Authors:  P Parham; C E Lomen; D A Lawlor; J P Ways; N Holmes; H L Coppin; R D Salter; A M Wan; P D Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

8.  A monoclonal antibody directed against the HLA-Bw6 epitope.

Authors:  S F Radka; D D Kostyu; D B Amos
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

9.  Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes.

Authors:  S Y Yang; Y Morishima; N H Collins; T Alton; M S Pollack; E J Yunis; B Dupont
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

Authors:  B T Spear; J Kornbluth; J L Strominger; D B Wilson
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307
View more
  8 in total

1.  A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis.

Authors:  Naiara Santana-Codina; Rafael Carretero; Rebeca Sanz-Pamplona; Teresa Cabrera; Emre Guney; Baldo Oliva; Philippe Clezardin; Omar E Olarte; Pablo Loza-Alvarez; Andrés Méndez-Lucas; Jose Carlos Perales; Angels Sierra
Journal:  Mol Cell Proteomics       Date:  2013-04-26       Impact factor: 5.911

2.  Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphism Relevant to Inflammatory Disease Shapes the Peptidome of the Birdshot Chorioretinopathy-Associated HLA-A*29:02 Antigen.

Authors:  Carlos Alvarez-Navarro; Adrian Martín-Esteban; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2015-04-19       Impact factor: 5.911

3.  Characterization of a new and highly distinguishable HLA-A allele in a Spanish family.

Authors:  A Balas; F Garcia-Sanchez; F Gomez-Reino; J L Vicario
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Allele-specific Alterations in the Peptidome Underlie the Joint Association of HLA-A*29:02 and Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) with Birdshot Chorioretinopathy.

Authors:  Alejandro Sanz-Bravo; Adrian Martín-Esteban; Jonas J W Kuiper; Marina García-Peydró; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2018-05-16       Impact factor: 5.911

5.  Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Authors:  Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera
Journal:  Immunogenetics       Date:  2008-06-11       Impact factor: 2.846

6.  HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.

Authors:  Francisco Perea; Abel Sánchez-Palencia; Mercedes Gómez-Morales; Mónica Bernal; Ángel Concha; Míguela Méndez García; Amanda Rocío González-Ramírez; Martin Kerick; Javier Martin; Federico Garrido; Francisco Ruiz-Cabello; Natalia Aptsiauri
Journal:  Oncotarget       Date:  2017-12-19

7.  Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

Authors:  Greta Garrido; Ailem Rabasa; Cristina Garrido; Lisset Chao; Federico Garrido; Ángel M García-Lora; Belinda Sánchez-Ramírez
Journal:  Front Pharmacol       Date:  2017-10-06       Impact factor: 5.810

8.  Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.

Authors:  Hernani Gil-Julio; Francisco Perea; Antonio Rodriguez-Nicolas; Jose Manuel Cozar; Amanda Rocío González-Ramirez; Angel Concha; Federico Garrido; Natalia Aptsiauri; Francisco Ruiz-Cabello
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.